Kiora PharmaceuticalsKPRX
13F holders, Q1 2024 (March 31)24holders
1famous investor
$0.71avg. 13F price*
At the end of Q1 2024, 24 institutions reported holding Kiora Pharmaceuticals Inc. (KPRX) in their 13F filings. The largest holders were Rosalind Advisors, Inc. ($1.6M), AIGH Capital Management LLC ($1.6M) and Alyeska Investment Group, L.P. ($1.6M). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Kiora Pharmaceuticals Inc.
- CUSIP
- 49721T309
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 11 | $7.7M |
| Exits | 2 | $50K |
Ownership 24 holders
| Rosalind Advisors, Inc. | 1.52% | New | 2,300,000 | $1.6M |
| AIGH Capital Management LLC | 0.78% | New | 2,300,000 | $1.6M |
| Alyeska Investment Group, L.P. | 0.01% | New | 2,200,000 | $1.6M |
| Nantahala Capital Management, LLC | 0.13% | New | 1,900,000 | $1.3M |
| Velan Capital Investment Management LP | 0.42% | New | 1,100,000 | $777K |
| ADAR1 Capital Management, LLC | 0.21% | New | 1,100,000 | $777K |
| Captrust Financial Advisors | 0.00% | No change | 80,000 | $56K |
| Geode Capital Management, LLC | 0.00% | No change | 37,211 | $26K |
| XTX Topco Ltd | 0.00% | New | 24,909 | $18K |
| Vanguard Group Inc. | 0.00% | No change | 24,566 | $17K |
| HRT Financial LP | 0.00% | New | 22,864 | $16K |
| Renaissance Technologies | 0.00% | Reduce -10.9% | 16,655 | $12K |
| BlackRock Inc. | 0.00% | Reduce -0.0% | 14,461 | $10K |
| Two Sigma Investments, LP | 0.00% | New | 10,351 | $7K |
| Virtu Financial LLC | 0.00% | Reduce -64.1% | 10,207 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +0.3% | 4,187 | $3K |
| NewEdge Advisors, LLC | 0.00% | No change | 200 | $141 |
| US Bancorp \de | 0.00% | No change | 67 | $47 |
| Wells Fargo & Company | 0.00% | Add +1.7% | 60 | $42 |
| Osaic Holdings, Inc. | 0.00% | No change | 36 | $25 |
| Morgan Stanley | 0.00% | No change | 8 | $6 |
| FMR LLC | 0.00% | New | 7 | $5 |
| Albion Financial Group | 0.00% | No change | 6 | $5 |
| JPMorgan Chase & Co. | 0.00% | New | 4 | $3 |
"% of holder's portfolio" is KPRX's weight in each manager's 13F, not the share of Kiora Pharmaceuticals Inc. the manager owns.